Skip to main content
. 2013 Dec 20;13:340. doi: 10.1186/1471-244X-13-340

Table 7.

Benefit/risk ratio for LAI FGA and LAI SGA in schizophrenia

  Prevention of psychotic recurrence
1 st line treatment
Risperidone LAI
2 nd line treatment Olanzapine pamoate
Haloperidol decanoate
Zuclopenthixol decanoate
Flupentixol decanoate
Fluphenazine decanoate
Pipotiazine palmitate